Tag:
emerging markets
Latest Headlines
Latest Headlines
J&J's Gorsky will target device deals for emerging markets
Expect Johnson & Johnson ($JNJ) to start spending some of its $14 billion in cash on medical device deals to help expand its presence in emerging markets once Alex Gorsky becomes CEO.
Malaysian genericsmaker in talks to buy manufacturing facility in Indonesia
Yusoff Rahman, CEO of generic drug manufacturer Pharmaniaga, confirmed the company has set aside $10 million to acquire an API plant in Indonesia.
Phosphagenics brings transdermal tech to India with Intas deal
Australia's Phosphagenics is looking to tap the Indian market, inking a deal with Intas Pharmaceuticals to push its transdermal platform there.
IOM gives FDA to-do list for securing global drug supplies
U.S. regulators can't go solo on securing the U.S. drug supply, nor can the FDA afford to count on agencies in developing nations, IOM says.
Hikma to plow $300M into M&A, internal growth
Hikma Pharmaceuticals may not be a Big Pharma, but it has big pharma plans.
U.S. questions India's IP regime after Nexavar move
Is intellectual property safe in India? That's the question drugmakers--and now U.S. officials--are asking.
M&A in Turkey, Indonesia underscore emerging-markets lure
Given the measly growth projections for U.S. and Europe, it's no surprise that expansion-minded drugmakers are looking eastward.
AstraZeneca's R&D chief in China lays out $100M strategy
One of the hottest trends in the global R&D business in recent years has been Big Pharma's huge investment in China. Among all the emerging countries, China's massive, fast-growing economy has
R&D execs continue the global search for efficiency, open innovation
Throughout 2011 we've seen a continuation of an intense reengineering of the development process at a slate of Big Pharma companies. Pfizer ( $PFE ), of course, grabbed the biggest headlines as it
AZ ups emerging markets bet with $200M plant in China
AstraZeneca ( $AZN ) has announced a $200 million investment to build a pharma manufacturing plant in China Medical City, Jiangsu Province. The company says the financial commitment is its largest ever
